Skip to main content
. 2024 Jul 6;10(14):e34239. doi: 10.1016/j.heliyon.2024.e34239

Table 3.

Comprehensive review of clinical presentations, laboratory diagnostics, radiological insights, and therapeutic interventions for insulinoma during pregnancy.

Patient Year Age (years) Symptom onset Blood sugar (mmol/L) Insulin (pmol/L) C-peptide (nmol/L) Pro-insulin Radiological findings Management
1 [8] 1977 21 Gestation:
1st trimester
2 1861.1 N/A N/A Splenic angio: 2 cm tumor in pancreatic body. During pregnancy. Laparotomy. Gestation: week 12.
2 [9] 1983 33 Gestation: week 7 1.5 208.3–277.8 N/A 0.2 pmol/ml US, CT: 2 cm tumor in pancreatic head. Both during pregnancy. Laparotomy. Gestation: week 17.
3 [10] 1984 19 Gestation:
1st trimester
1.7 399.3 0.33 N/A CT, angio: 1.8 × 2.6 cm2 tumor in pancreatic tail. Both during pregnancy. Laparotomy post-pregnancy termination. 1st trimester.
4 [11] 1985 24 Gestation: week 10 1.2 201.4 1.19 0.1 μ U/ml CT: no evidence of tumor. Angio: tumor in pancreatic body. Both post-delivery. Laparotomy. Post-delivery.
5 [12] 1986 24 Gestation: week 6 0.6 1006.9 0.77 N/A US, CT, angio: no evidence of tumor. All post-delivery. Laparotomy. Post-delivery
6 [13] 1988 37 Gestation: week 35 1.1 631.9 N/A N/A US: no evidence of tumor. During pregnancy. Liver examination during caesarean section showed multiple nodules of malignant insulinoma (died post-surgery day 10 due to progressive hepatic failure).
7 [14] 1988 41 Gestation:
1st trimester
1.9 437.5 N/A N/A CT, angio: no evidence of tumor. Both post-delivery. Laparotomy. Post-delivery.
8 [15] 1990 26 Gestation: week 16 1 104.2 2.28 N/A CT, angio: 2-cm tumor in pancreatic tail. Both post-delivery. Laparotomy. Post-delivery.
9 [16] 1991 25 Gestation:
1st trimester
1.9 368.1 0.02 N/A US: no evidence of tumor. During pregnancy. Laparotomy. 1st trimester.
10 [17] 1992 30 Gestation: week 16 0.7 184 N/A N/A Autopsy (died 2 weeks post-delivery due to severe sepsis).
11 [18] 1992 24 Gestation:
1st trimester
1.3 54 N/A N/A US: no evidence of tumor. MRI: tumor in pancreatic tail. Both during pregnancy. Exploratory laparotomy with resection of distal pancreas (2nd trimester). A 2nd laparotomy with tumor resection post-delivery.
12 [19] 1994 26 Gestation: week 16 1.7 493.1 3 N/A CT: 1-cm tumor in pancreatic tail. Post-delivery. Laparotomy. Post-delivery.
13 [20] 1994 25 Gestation: week 6 1.9 187.5 N/A N/A US, EUS: no evidence of tumor. Both during pregnancy. Laparotomy. Gestation: week 17.
14 [21] 2001 36 Postpartum: day 1 1.2 N/A N/A N/A CT: 1.5-cm tumor in pancreatic head. Post-delivery. Laparotomy. Post-delivery.
15 [22] 2002 26 Gestation: week 6 1.3 909.7 0.03 N/A MRI, CT: tumor in pancreatic tail. Both post-delivery. Laparotomy. Post-delivery.
16 [23] 2002 35 Postpartum: week 3 2.1 104.2 2 N/A US, CT, intraarterial calcium stimulation: no evidence of tumor. All post-delivery. Laparotomy. Post-delivery.
17 [24] 2008 35 Postpartum: month 3 1.5 178.5 0.89 N/A CT, angiography: no evidence of tumor. Both post-delivery. Laparotomy. Post-delivery.
18 [24] 2008 35 Postpartum: day 26 1.9 47.2 0.29 N/A CT, EUS, intraarterial calcium stimulation: no evidence of tumor. All post-delivery. Laparoscopy. Post-delivery.
19 [24] 2008 22 Gestation: month 2 2.3 477.1 N/A N/A MRI: 2.5-cm cystic tumor in pancreatic tail. EUS: 1.2 × 2 cm2 cystic tumor and 1.7 × 1.5 cm2 solid hypoechoic lesion. Both post-delivery. Laparoscopy. Post-delivery.
20 [25] 2008 29 Gestation: week 35 0.9 51 0.76 45 pmol/l US, CT, MRI, somatostatin receptor scintigraphy: no evidence of tumor. Intraoperative US: 5-mm tumor in pancreatic head. All post-delivery. Laparotomy. Post-delivery.
21 [26] 2008 26 Postpartum: day 3 1.3 38.9 0.35 16 pmol/l MRI: 1.2-cm tumor in pancreatic head. Post-delivery. Laparotomy. Post-delivery.
22 [28] 2012 29 Gestation: week 17 1.6 N/A N/A N/A US: innumerable hypoechoic liver lesions. MRI: innumerable T2-hyperintense lesions throughout liver. Both during pregnancy. Therapy with everolimus. Post-delivery.
23 [29] 2012 21 Postpartum: day 8 2.1 54 N/A N/A CT: 2-cm tumor in pancreatic head. Post-delivery. Laparoscopic enucleation of tumor. Post-delivery.
24 [30] 2015 38 Postpartum: week 3 1.5 67.4 0.52 N/A US: no evidence of tumor. EUS: hypoechoic lesion (8 × 9 mm2) in pancreatic head. Both post-delivery. Laparotomy. Post-delivery
25 [31] 2017 36 Gestation: week 17 2.7 29.5 0.54 7.49 μ U/ml EUS: 1.8 × 2.2 cm2 tumor in pancreatic tail. MRI: 2-cm hyperintense solid lesion in pancreatic tail. Both during pregnancy. Laparotomy in 2nd trimester. Gestation: week 21.
26 [32] 2020 34 Postpartum: day 2 2 300 1.62 N/A US: no evidence of tumor. MRI: 10 × 8 mm2 lesion in pancreatic head. EUS: 14.3 mm lesion in pancreatic head. All post-delivery. Laparotomy. Post-delivery.
27
Our case
2020 30 Gestation: week 13 1.4 79.2 0.51 N/A MRI: 2.0 × 1.6 cm2 tumor in pancreatic body. During pregnancy. Robotic-assisted pancreatic enucleation. Gestation: week 18.

Angio, angiography; CT, computed tomography; EUS, endoscopic ultrasound; MRI, magnetic resonance imaging; N/A, not available; US, ultrasound.